IL13 polymorphisms were proposed as PsA markers among psoriasis patients in the earlier reports [87,88] but this gene was later identified as a risk region for cutaneous-only psoriasis as well albeit with a weaker association in a large GWAS meta-analysis [13]. This evidence concerns the gene IL13 and psoriasis.